Albuterol Sulfate Solution Shortage: Latest Updates and Availability
The FDA has listed Albuterol Sulfate Solution as a current shortage, affecting medications used in pediatric and pulmonary care.
What’s in Shortage
Albuterol Sulfate Solution is currently listed as being in shortage. This medication, which includes the brand name ALBUTEROL SULFATE INHALATION SOLUTION, 0.5%, is a solution used primarily in pediatric and pulmonary/allergy therapeutic categories.
Which Manufacturers Are Affected
The following manufacturer is listed in the database:
- Ritedose Pharmaceuticals, LLC: Status is currently Available.
- Presentation: Albuterol Sulfate, Solution, 2.5 mg/.5 mL (NDC 76204-027-01)
- Contact: 803-806-3300
Why There’s a Shortage
No specific reason for the shortage of Albuterol Sulfate Solution was provided in the current FDA report.
What Patients Should Do
Patients who depend on this medication for respiratory health should take the following steps:
- Consult your pharmacist to check the current stock levels at your local pharmacy.
- Contact the manufacturer (Ritedose Pharmaceuticals at 803-806-3300) if you have specific questions about supply.
- Speak with your healthcare provider to discuss your treatment plan and any concerns regarding availability.
Disclaimer: Patients should always consult their healthcare provider for medical advice and before making any changes to their medication regimen.
Source
Information provided by the FDA Drug Shortage Database. Initial posting date: 10/25/2022. Last updated: 03/02/2026.
Source: FDA Official Notice
Related Articles
Conivaptan Hydrochloride Injection Shortage: Current Availability and Shipping Updates
FDA · April 3, 2026
Promethazine Hydrochloride Injection Shortage: Current Status and Manufacturer Updates
FDA · March 21, 2026
Cefotaxime Sodium Powder for Solution Shortage: Current Status and Manufacturer Updates
FDA · March 21, 2026